These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21896153)

  • 1. PROGRESS: Prevention of Recurrent Stroke.
    Arima H; Chalmers J
    J Clin Hypertens (Greenwich); 2011 Sep; 13(9):693-702. PubMed ID: 21896153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of blood pressure lowering on major vascular events among patients with isolated diastolic hypertension: the perindopril protection against recurrent stroke study (PROGRESS) trial.
    Arima H; Anderson C; Omae T; Woodward M; Hata J; Murakami Y; Macmahon S; Neal B; Chalmers J;
    Stroke; 2011 Aug; 42(8):2339-41. PubMed ID: 21700945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
    Arima H; Hart RG; Colman S; Chalmers J; Anderson C; Rodgers A; Woodward M; MacMahon S; Neal B;
    Stroke; 2005 Oct; 36(10):2164-9. PubMed ID: 16141420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
    Chapman N; Huxley R; Anderson C; Bousser MG; Chalmers J; Colman S; Davis S; Donnan G; MacMahon S; Neal B; Warlow C; Woodward M;
    Stroke; 2004 Jan; 35(1):116-21. PubMed ID: 14671247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial.
    Arima H; Tzourio C; Butcher K; Anderson C; Bousser MG; Lees KR; Reid JL; Omae T; Woodward M; MacMahon S; Chalmers J;
    Stroke; 2006 Jun; 37(6):1497-502. PubMed ID: 16627794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy.
    Dufouil C; Chalmers J; Coskun O; Besançon V; Bousser MG; Guillon P; MacMahon S; Mazoyer B; Neal B; Woodward M; Tzourio-Mazoyer N; Tzourio C;
    Circulation; 2005 Sep; 112(11):1644-50. PubMed ID: 16145004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of Perindopril in the reduction of cardiovascular events.
    Campbell DJ
    Vasc Health Risk Manag; 2006; 2(2):117-24. PubMed ID: 17319455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation.
    Chalmers J; MacMahon S
    J Hypertens Suppl; 2003 Jun; 21(5):S9-14. PubMed ID: 12953850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.
    Fransen M; Anderson C; Chalmers J; Chapman N; Davis S; MacMahon S; Neal B; Sega R; Terent A; Tzourio C; Woodward M;
    Stroke; 2003 Oct; 34(10):2333-8. PubMed ID: 12958329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Perindopril Protection Against Recurrent Stroke Study (PROGRESS): clinical implications for older patients with cerebrovascular disease.
    Ratnasabapathy Y; Lawes CM; Anderson CS
    Drugs Aging; 2003; 20(4):241-51. PubMed ID: 12641480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trials on blood pressure-lowering and secondary stroke prevention.
    Chalmers J
    Am J Cardiol; 2003 May; 91(10A):3G-8G. PubMed ID: 12781902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
    Tzourio C; Anderson C; Chapman N; Woodward M; Neal B; MacMahon S; Chalmers J;
    Arch Intern Med; 2003 May; 163(9):1069-75. PubMed ID: 12742805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial.
    Ninomiya T; Perkovic V; Gallagher M; Jardine M; Cass A; Arima H; Anderson C; Neal B; Woodward M; Omae T; MacMahon S; Chalmers J;
    Kidney Int; 2008 Apr; 73(8):963-70. PubMed ID: 18272959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of the month. Secondary prevention of cerebrovascular accident with perindopril: the PROGRESS study].
    Scheen AJ
    Rev Med Liege; 2001 Nov; 56(11):792-5. PubMed ID: 11789395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in secondary prevention of stroke with PROGRESS. The perindopril protection against recurrent stroke study.
    Schiffrin EL
    Curr Hypertens Rep; 2002 Feb; 4(1):39-40. PubMed ID: 11790290
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan.
    Hasegawa Y; Yamaguchi T; Omae T; Woodward M; Chalmers J;
    Hypertens Res; 2004 Mar; 27(3):147-56. PubMed ID: 15080373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial.
    Czernichow S; Ninomiya T; Huxley R; Kengne AP; Batty GD; Grobbee DE; Woodward M; Neal B; Chalmers J
    Hypertension; 2010 May; 55(5):1193-8. PubMed ID: 20212271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.
    Bath P
    Stroke; 2003 May; 34(5):1334-5. PubMed ID: 12702833
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: should this progress matter to patients?
    Schiffrin EL
    Circulation; 2005 Sep; 112(11):1525-6. PubMed ID: 16157782
    [No Abstract]   [Full Text] [Related]  

  • 20. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
    J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.